» Articles » PMID: 34696320

Markers of Gut Barrier Function and Microbial Translocation Associate with Lower Gut Microbial Diversity in People with HIV

Overview
Journal Viruses
Publisher MDPI
Specialty Microbiology
Date 2021 Oct 26
PMID 34696320
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

People with human immunodeficiency virus (HIV) (PWH) have reduced gut barrier integrity ("leaky gut") that permits diffusion of microbial antigens (microbial translocation) such as lipopolysaccharide (LPS) into the circulation, stimulating inflammation. A potential source of this disturbance, in addition to gut lymphoid tissue CD4+ T-cell depletion, is the interaction between the gut barrier and gut microbes themselves. We evaluated the relationship of gut barrier integrity, as indexed by plasma occludin levels (higher levels corresponding to greater loss of occludin from the gut barrier), to gut microbial diversity. PWH and people without HIV (PWoH) participants were recruited from community sources and provided stool, and 16S rRNA amplicon sequencing was used to characterize the gut microbiome. Microbial diversity was indexed by Faith's phylogenetic diversity (PD). Participants were 50 PWH and 52 PWoH individuals, mean ± SD age 45.6 ± 14.5 years, 28 (27.5%) women, 50 (49.0%) non-white race/ethnicity. PWH had higher gut microbial diversity (Faith's PD 14.2 ± 4.06 versus 11.7 ± 3.27; = 0.0007), but occludin levels were not different (1.84 ± 0.311 versus 1.85 ± 0.274; = 0.843). Lower gut microbial diversity was associated with higher plasma occludin levels in PWH (r = -0.251; = 0.0111), but not in PWoH. A multivariable model demonstrated an interaction ( = 0.0459) such that the correlation between Faith's PD and plasma occludin held only for PWH (r = -0.434; = 0.0017), but not for PWoH individuals (r = -0.0227; = 0.873). The pattern was similar for Shannon alpha diversity. Antiretroviral treatment and viral suppression status were not associated with gut microbial diversity (ps > 0.10). Plasma occludin levels were not significantly related to age, sex or ethnicity, nor to current or nadir CD4 or plasma viral load. Higher occludin levels were associated with higher plasma sCD14 and LPS, both markers of microbial translocation. Together, the findings suggest that damage to the gut epithelial barrier is an important mediator of microbial translocation and inflammation in PWH, and that reduced gut microbiome diversity may have an important role.

Citing Articles

Gut Microbiome Alteration in HIV/AIDS and the Role of Antiretroviral Therapy-A Scoping Review.

Gaspar Z, Nagavci B, Szabo B, Lakatos B Microorganisms. 2024; 12(11).

PMID: 39597610 PMC: 11596264. DOI: 10.3390/microorganisms12112221.


Oxidative phosphorylation in HIV-1 infection: impacts on cellular metabolism and immune function.

Rodriguez N, Fortune T, Hegde E, Weinstein M, Keane A, Mangold J Front Immunol. 2024; 15():1360342.

PMID: 38529284 PMC: 10962326. DOI: 10.3389/fimmu.2024.1360342.


Opioids and Immunosuppression: Clinical Evidence, Mechanisms of Action, and Potential Therapies.

Bettinger J, Friedman B Palliat Med Rep. 2024; 5(1):70-80.

PMID: 38435086 PMC: 10908329. DOI: 10.1089/pmr.2023.0049.


Cenicriviroc prevents dysregulation of astrocyte/endothelial cross talk induced by ischemia and HIV-1 via inhibiting the NLRP3 inflammasome and pyroptosis.

Fattakhov N, Ngo A, Torices S, Joseph J, Okoro A, Moore C Am J Physiol Cell Physiol. 2023; 326(2):C487-C504.

PMID: 38145295 PMC: 11192487. DOI: 10.1152/ajpcell.00600.2023.


Immune activation and inflammation in lactating women on combination antiretroviral therapy: role of gut dysfunction and gut microbiota imbalance.

Munjoma P, Chandiwana P, Wyss J, Mazhandu A, Jordi S, Gutsire R Front Immunol. 2023; 14:1280262.

PMID: 38045684 PMC: 10693333. DOI: 10.3389/fimmu.2023.1280262.


References
1.
Somsouk M, Estes J, Deleage C, Dunham R, Albright R, Inadomi J . Gut epithelial barrier and systemic inflammation during chronic HIV infection. AIDS. 2014; 29(1):43-51. PMC: 4444362. DOI: 10.1097/QAD.0000000000000511. View

2.
Imai K, Yamada K, Tamura M, Ochiai K, Okamoto T . Reactivation of latent HIV-1 by a wide variety of butyric acid-producing bacteria. Cell Mol Life Sci. 2012; 69(15):2583-92. PMC: 11114855. DOI: 10.1007/s00018-012-0936-2. View

3.
Peng L, Li Z, Green R, Holzman I, Lin J . Butyrate enhances the intestinal barrier by facilitating tight junction assembly via activation of AMP-activated protein kinase in Caco-2 cell monolayers. J Nutr. 2009; 139(9):1619-25. PMC: 2728689. DOI: 10.3945/jn.109.104638. View

4.
Berkes J, Viswanathan V, Savkovic S, Hecht G . Intestinal epithelial responses to enteric pathogens: effects on the tight junction barrier, ion transport, and inflammation. Gut. 2003; 52(3):439-51. PMC: 1773546. DOI: 10.1136/gut.52.3.439. View

5.
Brenchley J, Schacker T, Ruff L, Price D, Taylor J, Beilman G . CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract. J Exp Med. 2004; 200(6):749-59. PMC: 2211962. DOI: 10.1084/jem.20040874. View